OMEGA THERAPEUTICS INC (OMGA)
US68217N1054 - Common Stock
ChartMill assigns a Buy % Consensus number of 85% to OMGA. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 12.07. This target is 415.81% above the current price.
OMGA was analyzed by 12 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about OMGA.
In the previous month the buy percentage consensus was at a similar level.
OMGA was analyzed by 12 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-04-03 | Piper Sandler | Reiterate | Overweight -> Overweight |
| 2024-04-01 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-01-04 | Wedbush | Reiterate | Outperform -> Outperform |
| 2023-11-13 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-11-10 | Wedbush | Maintains | Outperform -> Outperform |
| 2023-09-01 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-08-04 | Chardan Capital | Reiterate | Buy -> Buy |
| 2023-06-06 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-05-08 | Chardan Capital | Reiterate | Buy |
| 2023-03-31 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-03-24 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-03-10 | JonesTrading | Initiate | Buy |
| 2023-03-03 | Piper Sandler | Maintains | Overweight |
| 2022-12-08 | HC Wainwright & Co. | Initiate | Buy |
| 2022-09-23 | Chardan Capital | Initiate | Buy |
| 2022-05-24 | Goldman Sachs | Maintains | Neutral |
| 2022-05-23 | Piper Sandler | Maintains | Overweight |
| 2021-08-24 | Wedbush | Initiate | Outperform |
| 2021-08-24 | Goldman Sachs | Initiate | Neutral |
| 2021-08-24 | Piper Sandler | Initiate | Overweight |
| 2021-08-24 | Jefferies | Initiate | Buy |